Holista CollTech joins forces with GICC to develop works first nasal sanitiser, page-1555

Quick calculation says :

80Less sale - $1.4m
SKN deal - $600k
Sales of Natshield @ 29/03=2 - $1.4m

So conservatively = $3.4m in Revenue Lets theorize a EBITDA of 50% of that, so $1.7m

Now as we know this company is growing and has already received a large order in the current quarter its fairly safe to say we can times that EBITDA by 4 - $1.7m x 4 = $6.8m for the year.

Now if we use a standard P/E ratio of 10 applied - $68m Market cap, HOWEVER one of our competitors ZNO is currently running on a P/E closer to 30, they are more advanced of course - But giving this fact a 50% discount above the standard P/E yet allowing for growth gives us $6.8m x 20 = $136m market cap

Share price at $136m - a share registry of cerca 251m would give a share price of approx = 54 cents a share,
Now even applying a 50% discount once again to that gives us a very base worth of 27 cents a share not taking into account this months order of Natshield or future growth.

All above is IMO but gives an idea what to expect in quarterly so people can understand the numbers a little better and what they mean.

EBITDA = Earnings before interest - tax - depreciation - amortization
P/E = Price to earnings ratio annnnnd my buy has been filled. Thankyou !